本文選題：藥師 + 居家用藥評估��； 參考：《中國現(xiàn)代應(yīng)用藥學(xué)》2016年01期

【摘要】：目的系統(tǒng)評價國內(nèi)外居家用藥評估(Home medicines review,HMR)服務(wù)的實施現(xiàn)狀。方法計算機檢索以下數(shù)據(jù)庫:Cochrane Library、Pub Med、Embase、CNKI、CBM、VIP和萬方數(shù)據(jù)庫,檢索時間截止2014年9月。納入HMR相關(guān)的中英文研究,對所納入的RCT文獻,采用Rev Man 5.1軟件進行Meta分析,其余文獻采用描述性分析。結(jié)果共納入27項研究,其中包括10項RCTs,17項其他研究。Meta分析顯示,HMR組較對照組的藥物相關(guān)問題減少20.8%~70.4%;HMR組的再入院率高于對照組(38.34%vs 33.63%),但差異無統(tǒng)計學(xué)意義(P=0.64);死亡率未明顯降低,差異無統(tǒng)計學(xué)意義。HMR組較對照組的滿意度高,2組HMR接受度及生活質(zhì)量評分差異均無統(tǒng)計學(xué)意義。HMR的實施困難包括醫(yī)師、藥師、患者及模式自身問題。結(jié)論實施HMR面臨多方面困難,HMR是否能顯著改善患者各項結(jié)局指標還有待更多大樣本、高質(zhì)量研究來證實。
[Abstract]:Objective to evaluate the status of Home medicines Review (HMRs) service at home and abroad. Methods the following databases were searched by computer: Cochrane Library Pub Medbase (CNKI) CBMU VIP and Wanfang database. The retrieval time was up to September 2014. The Chinese and English studies related to HMR were included. The RCT literature was analyzed by Rev Man 5.1 software and the rest by descriptive analysis. Results A total of 27 studies were included, including 10 RCTsN 17 other studies. Meta-analysis showed that the readmission rate in HMR group was higher than that in control group (38.34 vs 33.63), but there was no significant difference between HMR group and control group. The difference of HMR acceptance and quality of life score between the two groups was not statistically significant. The difficulty of implementing HMR included doctors, pharmacists, patients and the model itself. Conclusion there are many difficulties in the implementation of HMR.
【作者單位】： 重慶醫(yī)科大學(xué)附屬第一醫(yī)院藥學(xué)部;
【分類號】：R95
，

本文編號：1946671